Apellis Pharmaceuticals, Inc. (APLS)
24.96
+0.28
(+1.15%)
USD |
NASDAQ |
Dec 11, 16:00
24.94
-0.02
(-0.10%)
After-Hours: 07:20
Apellis Pharmaceuticals Free Cash Flow: 78.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biogen, Inc. | 2.262B |
| Amicus Therapeutics, Inc. | 9.691M |
| Fortress Biotech, Inc. | -30.14M |
| Ultragenyx Pharmaceutical, Inc. | -466.39M |
| Fulcrum Therapeutics, Inc. | -60.41M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 108.47M |
| Cash from Investing (Quarterly) | -0.148M |
| Cash from Financing (Quarterly) | 0.793M |
| Free Cash Flow Per Share (Quarterly) | 0.8328 |
| Free Cash Flow to Equity (Quarterly) | 102.71M |
| Free Cash Flow to Firm (Quarterly) | 119.57M |
| Free Cash Flow Yield | 2.49% |